Vaccines Get First Shot At Using Bar Code Alternatives As FDA Reconsiders Reg
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency seeks information on alternative technologies and the successes and challenges companies have faced in adopting linear bar codes for drug products.
You may also be interested in...
Bar Code Rule Could Be Revised Under FDA Reg Review Initiative
Technological advances allow the agency to consider alternatives to the requirements in the current rule, which became effective in 2006.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.